Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share (EVH)
CUSIP: 30050B101
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Class A Common Stock, par value $0.01 per share
- Shares outstanding
- 112,318,617
- Total 13F shares
- 131,673,312
- Share change
- +6,041,317
- Total reported value
- $1,482,570,130
- Put/Call ratio
- 67%
- Price per share
- $11.26
- Number of holders
- 218
- Value change
- +$78,519,495
- Number of buys
- 118
- Number of sells
- 109
Quarterly Holders Quick Answers
What is CUSIP 30050B101?
CUSIP 30050B101 identifies EVH - Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 30050B101:
Top shareholders of EVH - Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| CADIAN CAPITAL MANAGEMENT, LP |
13D/G
13F
|
Company |
9.3%
|
10,794,606
|
$106,218,923 | $0 | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
9.7%
|
10,938,156
|
$103,584,338 | — | 31 Mar 2025 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
13D/G
|
Company |
0.4%
from 13D/G
|
10,224,211
|
$96,823,278 | — | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
|
Company |
8.2%
|
9,229,054
|
$87,399,140 | — | 31 Mar 2025 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
5.4%
|
6,077,191
|
$57,555,396 | — | 31 Mar 2025 | |
| Engaged Capital LLC |
13F
|
Company |
4.6%
|
5,179,468
|
$49,049,562 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
4.3%
|
4,780,688
|
$45,273,119 | — | 31 Mar 2025 | |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
3.9%
|
4,403,937
|
$41,705,283 | — | 31 Mar 2025 | |
| RA CAPITAL MANAGEMENT, L.P. |
13D/G
|
— |
3.1%
|
3,577,197
|
$35,199,618 | $0 | 31 Dec 2024 | |
| FMR LLC |
13F
|
Company |
2.9%
|
3,206,133
|
$30,362,080 | — | 31 Mar 2025 | |
| Camber Capital Management LP |
13F
|
Company |
2.7%
|
3,000,000
|
$28,410,000 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
2.6%
|
2,931,344
|
$27,759,828 | — | 31 Mar 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
2.6%
|
2,924,352
|
$27,693,612 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
2.5%
|
2,836,402
|
$26,860,727 | — | 31 Mar 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
2.5%
|
2,829,060
|
$26,791,446 | — | 31 Mar 2025 | |
| Rock Springs Capital Management LP |
13F
|
Company |
2.4%
|
2,695,700
|
$25,528,279 | — | 31 Mar 2025 | |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND |
13F
|
Company |
2.4%
|
2,659,200
|
$25,182,624 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.3%
|
2,587,487
|
$24,509,412 | — | 31 Mar 2025 | |
| Frank J. Williams |
3/4/5
|
Director |
—
mixed-class rows
|
903,126
mixed-class rows
|
$24,140,121 | — | 01 Jun 2023 | |
| UBS Group AG |
13F
|
Company |
2.3%
|
2,542,214
|
$24,074,767 | — | 31 Mar 2025 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
1.7%
|
1,879,000
|
$17,794,130 | — | 31 Mar 2025 | |
| SILVERCREST ASSET MANAGEMENT GROUP LLC |
13F
|
Company |
1.5%
|
1,729,425
|
$16,377,655 | — | 31 Mar 2025 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
1.3%
|
1,487,896
|
$14,090,375 | — | 31 Mar 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
1.3%
|
1,470,200
|
$13,922,794 | — | 31 Mar 2025 | |
| Granahan Investment Management, LLC |
13F
|
Company |
1.2%
|
1,361,830
|
$12,896,530 | — | 31 Mar 2025 | |
| Sea Cliff Partners Management, LP |
13F
|
Company |
1.1%
|
1,250,158
|
$11,838,996 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1.1%
|
1,203,501
|
$11,397,153 | — | 31 Mar 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
1%
|
1,165,663
|
$11,038,829 | — | 31 Mar 2025 | |
| GLENMEDE TRUST CO NA |
13F
|
Company |
0.99%
|
1,109,427
|
$10,506,273 | — | 31 Mar 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.96%
|
1,083,637
|
$10,262,042 | — | 31 Mar 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.91%
|
1,023,077
|
$9,688,539 | — | 31 Mar 2025 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.9%
|
1,015,444
|
$9,616,255 | — | 31 Mar 2025 | |
| Rock Point Advisors, LLC |
13F
|
Company |
0.73%
|
824,535
|
$7,808,346 | — | 31 Mar 2025 | |
| GABELLI FUNDS LLC |
13F
|
Company |
0.63%
|
708,115
|
$6,705,849 | — | 31 Mar 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.58%
|
655,464
|
$6,207,244 | — | 31 Mar 2025 | |
| Rubicon Founders LLC |
13F
|
Company |
0.58%
|
653,523
|
$6,188,863 | — | 31 Mar 2025 | |
| TUDOR INVESTMENT CORP ET AL |
13F
|
Company |
0.58%
|
651,986
|
$6,174,307 | — | 31 Mar 2025 | |
| BLAIR WILLIAM & CO/IL |
13F
|
Company |
0.56%
|
624,640
|
$5,915,339 | — | 31 Mar 2025 | |
| Bellevue Group AG |
13F
|
Company |
0.55%
|
614,337
|
$5,817,771 | — | 31 Mar 2025 | |
| LAZARD ASSET MANAGEMENT LLC |
13F
|
Company |
0.53%
|
598,841
|
$5,671,000 | — | 31 Mar 2025 | |
| First Light Asset Management, LLC |
13F
|
Company |
0.52%
|
585,436
|
$5,544,079 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.51%
|
574,597
|
$5,441,432 | — | 31 Mar 2025 | |
| ROYCE & ASSOCIATES LP |
13F
|
Company |
0.51%
|
570,880
|
$5,406,234 | — | 31 Mar 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.49%
|
545,883
|
$5,169,512 | — | 31 Mar 2025 | |
| One68 Global Capital, LLC |
13F
|
Company |
0.47%
|
525,238
|
$4,974,004 | — | 31 Mar 2025 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.47%
|
522,956
|
$4,952,392 | — | 31 Mar 2025 | |
| Philosophy Capital Management LLC |
13F
|
Company |
0.46%
|
521,192
|
$4,935,688 | — | 31 Mar 2025 | |
| PEREGRINE CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.46%
|
521,058
|
$4,934,419 | — | 31 Mar 2025 | |
| CITIGROUP INC |
13F
|
Company |
0.46%
|
519,759
|
$4,922,118 | — | 31 Mar 2025 | |
| Steve Tutewohl |
3/4/5
|
Chief Operating Officer |
—
class O/S missing
|
136,331
|
$4,691,150 | — | 01 Jul 2023 |
Institutional Holders of Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share (EVH) as of Q2 2025
As of 30 Jun 2025,
Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share (EVH) was held by
218 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
131,673,312 shares.
The largest 10 holders included
VANGUARD GROUP INC, CADIAN CAPITAL MANAGEMENT, LP, BlackRock, Inc., MORGAN STANLEY, Durable Capital Partners LP, FMR LLC, Engaged Capital LLC, Rubicon Founders LLC, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, and EVENTIDE ASSET MANAGEMENT, LLC.
This page lists
219
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
222
Q2 2025 holders
218
Holder diff
-4
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.